Generating Reliable Results at the New Spectra Laboratory with Dr. Alex Ryder and Ines Dahne-Steuber
Release Date: 10/04/2021
Field Notes
info_outlineField Notes
info_outlineField Notes
info_outlineField Notes
info_outlineField Notes
info_outlineField Notes
info_outlineField Notes
info_outlineField Notes
info_outlineField Notes
April is National Donate Life Month, and during this time, we focus on raising awareness about transplantation and donation honor the people who have saved lives through the gift of donation. Tune in for this special episode today for an update on the latest in transplant medicine. Transplantation is the best method of treatment for many people with end stage kidney disease, when available and accessible. As a company, we prioritize expanding access to kidney transplantation and work to reduce the challenges facing patients as they work towards getting transplanted.
info_outlineField Notes
info_outlineResearch has shown that more than 70 percent of a person’s health care decisions are based on laboratory results. Ines Dahne-Steuber, president of Spectra Laboratories, and Dr. Alex Ryder, medical director, join Field Notes to discuss the importance of Spectra’s new state-of-the-art laboratory in Southaven, Mississippi, and its critical impact on the care delivered to patients across the country.